Neutrophil Count In African American Patients with Lung Cancer: Implications for Inclusion in Clinical Trials

被引：0
|
作者：
Narvel, H. [1 ]
Gor, R. [1 ]
Shivakumar, J. [2 ]
Yusuf, H. [1 ]
Pina, C. M. M. [1 ]
D'Aiello, A. [2 ]
Cheng, H. [2 ]
机构：
[1] Albert Einstein Coll Med, Jacobi Med Ctr, New York, NY USA
[2] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
neutropenia; lung cancer; Inclusivity in clinical trials;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA05.09
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [41] Absolute neutrophil count by Duffy status among healthy Black and African American adults
    Merz, Lauren E.
    Story, Charlotte M.
    Osei, Miriam A.
    Jolley, Katherine
    Ren, Siyang
    Park, Hae Soo
    Freedman, Revital Yefidoff
    Neuberg, Donna
    Smeland-Wagman, Robin
    Kaufman, Richard M.
    Achebe, Maureen O.
    BLOOD ADVANCES, 2023, 7 (03) : 317 - 320
  • [42] The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials
    Evans, Kiameesha R.
    Lewis, M. Jane
    Hudson, Shawna V.
    JOURNAL OF CANCER EDUCATION, 2012, 27 (02) : 299 - 305
  • [43] The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials
    Kiameesha R. Evans
    M. Jane Lewis
    Shawna V. Hudson
    Journal of Cancer Education, 2012, 27 : 299 - 305
  • [44] Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer
    Liu, Jie
    Hou, Wei
    Gonen, Mithat
    Seluzicki, Christina
    Li, Susan Qing
    Mao, Jun J.
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (02) : 1895 - 1903
  • [45] Inclusion of elderly patients in oncology clinical trials
    Le Saux, O.
    Falandry, C.
    Gan, H. K.
    You, B.
    Freyer, G.
    Peron, J.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1799 - 1804
  • [46] Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.
    Gerber, David E.
    Tri Le
    Yang, Hui
    Rashdan, Sawsan
    Alvarez, Carlos A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
    Sawsan Rashdan
    Hui Yang
    Tri Le
    Christopher Selby
    David E. Gerber
    Carlos A. Alvarez
    Clinical Drug Investigation, 2021, 41 : 161 - 167
  • [48] Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors
    Kumar, Gaurav
    Kim, Jungyoon
    Farazi, Paraskevi A.
    Wang, Hongmei
    Su, Dejun
    BMC CANCER, 2022, 22 (01)
  • [49] Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors
    Gaurav Kumar
    Jungyoon Kim
    Paraskevi A. Farazi
    Hongmei Wang
    Dejun Su
    BMC Cancer, 22
  • [50] Enrollment of lung cancer patients on clinical trials at an NCI comprehensive cancer center
    Horn, Leora
    Keedy, Vicki
    Campbell, Norma
    Garcia, Gabe
    Hayes, Amy
    Spencer, Brady
    Sandler, Alan
    Carbone, David
    Johnson, David H.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S661 - S661
12345